Atlas Trials

Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes

Clinical trial NCT00231192 · WITHDRAWN

Trial details

NCT number
NCT00231192
Sponsor
Children's Hospital of Philadelphia
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes
Start date
2005-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.